Table IV.
Analysis of miRNA expression levels in DLBCL vs. control groups (mean±SD).
Groups | miR-19a-3p | miR-19b-3p | miR-193a-3p | miR-370-3p | miR-1275 | miR-490-5p | miR-630 | miR-665 |
---|---|---|---|---|---|---|---|---|
Control (LRH) (n=15) | 1.134±0.576 | 1.132±0.503 | 1.200±0.722 | 1.172±0.728 | 1.186±0.788 | 1.164±0.655 | 1.095±0.524 | 1.085±0.430 |
DLBCL (n=15) | 0.882±0.648 | 0.578±0.382 | 0.548±0.252 | 0.236±0.192 | 1.299±0.753 | 0.456±0.326 | 2.145±1.235 | 1.440±0.948 |
T value | 1.126 | 3.397 | 3.299 | 4.817 | −0.401 | 3.742 | −3.030 | −1.319 |
P-value | 0.270 | 0.002 | 0.004 | 0.000 | 0.692 | 0.001 | 0.007 | 0.198 |
DLBCL, diffuse large B-cell lymphoma; LRH, lymph node reactive hyperplasia; miR/miRNA, microRNA.